Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-174204
Filing Date
2024-07-02
Accepted
2024-07-02 14:25:26
Documents
10
Period of Report
2024-07-02

Document Format Files

Seq Description Document Type Size
1 6-K d627610d6k.htm 6-K 10640
2 EX-99.1 d627610dex991.htm EX-99.1 16406
3 EX-99.2 d627610dex992.htm EX-99.2 37627
4 EX-99.3 d627610dex993.htm EX-99.3 12203
5 EX-99.4 d627610dex994.htm EX-99.4 34141
6 GRAPHIC g627610dsp4.jpg GRAPHIC 2253
7 GRAPHIC g627610g0702163606954.jpg GRAPHIC 2601
8 GRAPHIC g627610g0702163620479.jpg GRAPHIC 2601
9 GRAPHIC g627610g0702163630780.jpg GRAPHIC 2601
10 GRAPHIC g627610g0702163647475.jpg GRAPHIC 2601
  Complete submission text file 0001193125-24-174204.txt   130440
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 241094353
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)